Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 11, 2022
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myelomaDian Zhou, Ying Wang, Hai Cheng, et al.
Cancer|August 6, 2022
Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working GroupSha Ma, Bingpei Zhang, Tianyi Lu, et al.
Frontiers in Immunology|May 2, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapyLingling Yin, Bin Lv, Jiao Ge, et al.
ACS Omega|May 31, 2021
Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In VivoKe Qian, Chao-Yuan Tang, Li-Ying Chen, et al.
Cytotherapy|March 12, 2023
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myelomaSha Ma, Hujun Li, Dian Zhou, et al.
The Lancet. Haematology|July 26, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trialDian Zhou, Qian Sun, Jieyun Xia, et al.
Blood|May 21, 2026
Anti-BCMA/GPRC5D CAR T in relapsed or refractory multiple myeloma patients with extraosseous extramedullary diseaseDian Zhou, Yuekun Qi, Sha Ma, et al.
Blood|March 26, 2022
Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSLYuekun Qi, Mingfeng Zhao, Yongxian Hu, et al.
Blood|March 16, 2025
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myelomaSha Ma, Jieyun Xia, Miao Zhang, et al.
European Journal of Neurology|October 11, 2025
Characteristics and Prognosis of Functional Movement Disorders in China: FMD-China Registry StudyJin-Tao Wang, Ou-Mei Cheng, Gang Xu, et al.
Pageof 13